Wireless Cardiac Pulsatility Sensing for ICD Shock Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable cardioverter defibrillators (ICDs) often deliver unnecessary shocks due to false detection of arrhythmias, leading to patient discomfort and battery drain, as they struggle to differentiate between ventricular tachycardia/fibrillation and other conditions like supraventricular tachycardia or non-cardiac signals.
Innovation Solution
A system utilizing wireless transimpedance monitoring with distinct dipoles to measure cardiac pulsatility, allowing for more accurate detection of arrhythmias by measuring transimpedance changes through body tissue without shared electrodes, thereby reducing unnecessary shocks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If ICDs use traditional EGM signal sensing for arrhythmia detection, then arrhythmia detection capability is provided, but false detection occurs leading to unnecessary shocks
Solution Approach 1:
The patent introduces a new sensing modality (mechanical strain sensing via lead electrodes) as an intermediary to verify arrhythmia detection. The strain sensor acts as a mediator that provides independent confirmation of ventricular activity, allowing the system to distinguish true VT/VF from false detections caused by T-wave oversensing or SVT.
Solution Approach 2:
The patent replaces part of the electrical sensing system with a mechanical sensing system. Instead of relying solely on electrical EGM signals, the system uses mechanical strain sensors in the lead electrodes to detect physical movement of the heart, providing a different physiological basis for arrhythmia detection that is less susceptible to electrical interference.
2Reliability
If ICDs deliver shocks for detected arrhythmias, then life-saving therapy is provided, but battery energy is consumed
Solution Approach 1:
The patent implements feedback by continuously monitoring strain sensor signals and using them to confirm or refute arrhythmia detections before triggering shock therapy. The strain sensor provides real-time feedback on actual ventricular mechanical activity, allowing the control system to make informed decisions about shock delivery and avoid unnecessary energy consumption.
Solution Approach 2:
The strain sensing system serves itself by providing intrinsic verification of arrhythmia detection without requiring additional external components. The lead electrodes inherently sense mechanical strain during normal cardiac function, and this self-generated signal is used to validate arrhythmia detections and prevent false shock delivery.
3Measurement precision
If ICDs use multiple sensing modalities to reduce false detections, then detection accuracy improves, but device complexity increases
Solution Approach 1:
The patent makes the lead electrodes multi-functional by enabling them to serve both as electrical EGM sensing elements and as mechanical strain sensing elements. This universal use of existing components avoids the need for entirely separate sensing systems, thereby improving detection precision while limiting the increase in device complexity.
Solution Approach 2:
The patent merges electrical and mechanical sensing functions into a unified arrhythmia detection system. By combining EGM signal analysis with strain sensor data from the same lead electrodes, the system achieves more accurate detection without the complexity of completely separate sensing systems, as both modalities are integrated into a single control architecture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enhances the accuracy of arrhythmia detection, reducing the number of unnecessary shocks and conserving battery life by providing a more precise assessment of cardiac activity.
Implementation Method 1
a measurement dipole, distinct from and not electrically coupled to a common ground with the first dipole, is used to measure a voltage signal resulting from an injected current signal through a volume of body tissue
Data Source
Figure 1
Figure 2
Figure 3
AI summary
An implantable medical device system and associated method monitor changes in transimpedance in a body tissue due to changes in cardiac pulsatility. A first dipole is used to deliver a non-stimulating electrical current. The first dipole includes a first electrode and a second electrode adapted to be deployed along a first body location. A second dipole is used to measure a voltage resulting from the non-stimulating electrical current being conducted through a portion of a patient's body. The second dipole includes a third electrode and a fourth electrode different than the first electrode and the second electrode and adapted to be deployed along a second body location spaced apart from the first body location.